Review Article

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas

Table 2

Risk categories according to FLIPI2.

GroupNumber of factorsPercentage of patients3-year PFS (%)5-year PFS (%)HR (95% CI)

Low0209179.51.0
Intermediate1-25369513.19 (2.0–5.15)
High≥32751195.8 (3.5–9.4)